Search

Your search keyword '"Ling, Walter"' showing total 1,054 results

Search Constraints

Start Over You searched for: Author "Ling, Walter" Remove constraint Author: "Ling, Walter"
1,054 results on '"Ling, Walter"'

Search Results

3. Bupropion and Naltrexone in Methamphetamine Use Disorder

5. Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation

6. Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose.

8. Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment

9. Testing and linkage to HIV care in China: a cluster-randomised trial.

10. Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol

11. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction

12. Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone

13. Dose, Plasma Level, and Treatment Outcome Among Methadone Patients in Shanghai, China

15. A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here

16. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study

17. Injectable pharmacotherapy for opioid use disorders (IPOD)

18. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder

19. Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial

20. Loss to Follow-Up from HIV Screening to ART Initiation in Rural China.

21. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain

22. Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003

23. Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX)

24. Using behavioral economics to predict opioid use during prescription opioid dependence treatment

25. Efficacy of Cognitive Behavioral Therapy on Opiate Use and Retention in Methadone Maintenance Treatment in China: A Randomised Trial.

26. Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".

27. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study

28. Methylphenidate for methamphetamine use

29. HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.

30. Treatment retention on buprenorphine/methadone

31. Medication-assisted therapy for opioid addiction

32. Buprenorphine implants for opioid dependence

33. Medication-assisted treatment for opioid addiction: Methadone and buprenorphine

34. DSM-5 criteria for substance use disorders: recommendations and rationale.

35. The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction

36. Selective review and commentary on emerging pharmacotherapies for opioid addiction.

50. Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings.

Catalog

Books, media, physical & digital resources